HomeBusinessHealthcarePossible New Alzheimer's Drug: Annovis Bio (ANVS)
Possible New Alzheimer's Drug: Annovis Bio (ANVS)

Annovis Bio (ANVS) is developing a drug that improves cognition and motor function among patients with Alzheimer’s and Parkinson’s Diseases. Founder and CEO, Maria Maccecchini, discusses what separates the Annovis Bio treatment from other therapies. Annovis Bio’s stock hit an all-time high on May 25th and Maccecchini has a very positive outlook for the future of the drug and company. Tune in to find out more.

The Watch List

11 Jun 2021

ON AIR
education
6:00 am
Your First Trade
replay
12:00 am
Fast Market
REPLAY
education
1:00 am
Your First Trade
REPLAY
1:30 am
Next Gen Investing
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Trading 360
REPLAY
4:00 am
Fast Market
REPLAY
5:00 am
Next Gen Investing
REPLAY
ON AIR
education
6:00 am
Your First Trade
REPLAY
6:30 am
Trading 360
REPLAY
7:30 am
Fast Market
REPLAY
8:30 am
Next Gen Investing
REPLAY
education
9:30 am
Your First Trade
REPLAY
10:00 am
Trading 360
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Your First Trade
REPLAY
1:30 pm
Trading 360
REPLAY
2:30 pm
Fast Market
REPLAY
3:30 pm
Next Gen Investing
REPLAY
education
4:30 pm
Your First Trade
REPLAY
5:00 pm
Trading 360
REPLAY
6:00 pm
Fast Market
REPLAY
7:00 pm
Next Gen Investing
REPLAY
education
8:00 pm
Your First Trade
REPLAY
8:30 pm
Trading 360
REPLAY
9:30 pm
Fast Market
REPLAY
10:30 pm
Next Gen Investing
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US